Search

everythinglearnresearchcommunity

for

Search:↓

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Hair loss in men treated best with early medication or transplant, new treatments researched.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Coats' Plus is a genetic disorder with eye abnormalities, brain calcification, poor growth, bone and skin issues, and movement disorders.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Mutations in the DSG4 gene can cause a rare hair disorder similar to monilethrix.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Different types of facial fat affect aging and treatment outcomes; more research is needed to enhance anti-aging procedures.

Hair greying is caused by oxidative stress damaging hair follicles and melanocytes.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.